Whitehawk Therapeutics, Inc.
WHWKNasdaqCIK 1422142HealthcareFiscal year ends Dec 31
Reports and events: 237 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-1017:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-388010 |
| 2026-08-0616:03 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-337933 |
| 2026-08-0610:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-337069 |
| 2026-06-1216:19 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-269493 |
| 2026-05-2117:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-234890 |
| 2026-05-1819:03 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000935836-26-000289 |
| 2026-05-1420:04 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000902664-26-002450 |
| 2026-05-1308:08 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-220656 |
| 2026-05-0716:25 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-212075 |
| 2026-05-0709:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-210615 |
| 2026-04-2816:19 ET | DEF 14A | Proxy statementPeriod 2026-04-28 | 0001193125-26-187149 |
| 2026-03-1216:12 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-104158 |
| 2026-03-1208:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-103117 |
| 2025-11-0613:50 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-268895 |
| 2025-11-0608:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-268134 |
| 2025-08-0716:25 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-105081 |
| 2025-08-0708:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-104592 |
| 2025-06-1316:39 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-140810 |
| 2025-05-0817:28 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001628280-25-023932 |
| 2025-05-0816:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-023788 |
| 2025-04-2816:32 ET | DEF 14A | Proxy statementPeriod 2025-06-11 | 0001628280-25-020311 |
| 2025-03-3116:57 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001193125-25-068845 |
| 2025-03-2817:47 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001628280-25-015269 |
| 2025-03-2608:21 ET | 8-K | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001193125-25-063253 |
| 2025-03-1816:38 ET | 8-K | 2.02 Results of operations; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-25-056708 |
| 2025-03-0617:55 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-034969 |
| 2025-03-0515:58 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001373604-25-000045 |
| 2025-03-0417:58 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000902664-25-001335 |
| 2025-03-0416:16 ET | 8-K | 1.01 Entry into a material agreement; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-045605 |
| 2025-02-2411:38 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001373604-25-000038 |
| 2025-02-0411:11 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001373604-25-000005 |
| 2025-01-3015:32 ET | SCHEDULE 13D | Ownership report, active investor | 0001373604-25-000003 |
| 2025-01-2414:34 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000935836-25-000082 |
| 2024-12-3111:13 ET | SCHEDULE 13D | Ownership report, active investor | 0001373604-24-000118 |
| 2024-12-2317:26 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-24-139724 |
| 2024-12-2315:51 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000902664-24-007000 |
| 2024-12-2006:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-282407 |
| 2024-11-0616:08 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001628280-24-045698 |
| 2024-11-0608:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-045465 |
| 2024-10-0117:35 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-230376 |
| 2024-09-3006:06 ET | 8-K | 8.01 Other events | 0001193125-24-228322 |
| 2024-09-1916:13 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-222116 |
| 2024-08-2216:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-205370 |
| 2024-08-2121:21 ET | 8-K | 2.05 Exit or disposal costs; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-203889 |
| 2024-08-0716:16 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001628280-24-035636 |
| 2024-08-0708:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-035390 |
| 2024-06-1216:18 ET | 8-K | 5.07 Shareholder vote results | 0001628280-24-027826 |
| 2024-05-0816:05 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001628280-24-021657 |
| 2024-05-0808:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-021381 |
| 2024-04-2614:31 ET | DEF 14A | Proxy statementPeriod 2024-06-11 | 0001628280-24-018546 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:09 ET. Listed shows no prices and gives no investment advice.